Concepedia
Statistics
Publications
13
Citations
632
H-Index
11
Active since
2015
Affiliations
Université de Bourgogne(Current)
Université Bourgogne Franche-Comté
Inserm
Centre National de la Recherche Scientifique
Centre Georges François Leclerc
Lucile Dondaine is an author at Université de Bourgogne specializing in oncology, drug discovery, and medicinal chemistry.
Publications per year
2015–2024
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
Magalie Dosset, Thaiz Rivera Vargas, Anaïs Lagrange et al. · OncoImmunology · 2018 · 211 citations · Full text
Medicine, Immunology, Oncology +17
TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling
Pierre‐Marie Boutanquoi, Olivier Burgy, Guillaume Beltramo et al. · European Respiratory Journal · 2020 · 96 citations · Full text
Life Sciences, Molecular Biology, Pathobiology +17
Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy
Gustavo Jabor Gozzi, Daniel H. González, Christophe Boudesco et al. · Cell Death and Differentiation · 2019 · 65 citations · Full text
Medicine, Medicinal Chemistry, Oncology +9
Anticancer Agents: Does a Phosphonium Behave Like a Gold(I) Phosphine Complex? Let a “Smart” Probe Answer!
Moussa Ali, Lucile Dondaine, Anaïs Adolle et al. · Journal of Medicinal Chemistry · 2015 · 51 citations
Pharmacy, Medicinal Chemistry, Pharmacology +13
HSP110 translocates to the nucleus upon genotoxic chemotherapy and promotes DNA repair in colorectal cancer cells
Sébastien Causse, Guillaume Marcion, Gaëtan Chanteloup et al. · Oncogene · 2018 · 44 citations
Medicine, Molecular Biology, Oncology +12
1–5 of 13